A 41-year-old female was referred to our clinic with progressive dyspnea and a syncope, preceded by angina. On admission she was in cardiogenic shock. ECG showed diffuse repolarization changes and cardiac enzymes were elevated. The echocardiogram revealed severe left ventricular dysfunction with basal and medium walls hypokinesia. After stabilizing the patient, a coronary angiography was performed which revealed normal epicardial arteries. In the next days her clinical status was marked by severe hypertensive episodes with flash pulmonary edema and low responsiveness to therapy. Cardiovascular magnetic resonance showed myocardial edema and intramyocardial late gadolinium enhancement. An abdominal ultrasound raised suspicion of a pheochromocytoma due to an abnormal mass with cystic areas found on the right suprarenal gland. Elevated urinary free catecholamines and fractionated metanephrines confirmed the diagnosis. Further on, a CT scan better identified the heterogeneous tumor and the patient was referred for a right laparoscopic adrenalectomy. Followup at 1 month reported full recovery of the sistolic function. The particularity of the case is represented by the difficulty of diagnosis of adrenergic myocarditis, as well as the management of cardiogenic shock induced by it.
Introduction
Adrenergic myocarditis is a very rare presentation of pheochromocytoma and a particular cause of acute heart failure. Acute myocardial infarction, acute pulmonary edema, cardiac arrhythmias or cadiomyopathies are only few of myocardial dysfunctions seen in this pathology. Myocarditis, as a clinically significant condition, is extremely rare in pheochromocytoma, and most likely is provoked by a direct myocardial injury caused by catecholamines [1] . Adrenergic myocarditis complicated with cardiogenic shock is a therapeutic challenge due to the important limitations of disease pathogenesis.
Case report
A 41-year-old female, former smoker (12 pack-years), was referred to our clinic with 2 days progressive dyspnea and a syncope preceded by chest pain. She had a personal history of hypertension for 1 year and she took nebivolol 2.5 mg and lisinopril 10 mg, daily. On arrival, the patient was polypneic (24 breaths/minute), orthopneic, SpO2 =88% with oxygen therapy and a FiO 2 of 0.45, heart rate was 110 b.p.m. and blood pressure was 70/50 mmHg on both arms. Cardiac auscultation revealed a systolic murmur in mitral area and pulmonary auscultation was specific with acute pulmonary edema -diffuse crackles in all lung fields. She had a BMI of 24 kg/ m 2 and was afebrile.
An ECG (Figure 1 ) was obtained showing sinus rhythm of 110 b.p.m.; intermediate heart axis and normal conduction times; 1 mm concave ST-segment elevations in lead aVR; 3 mm ST -segment depression in leads V4-V6, negative T wave in lead aVL and flat in D1.
The initial etiological differential diagnosis for the cardiogenic shock included acute coronary syndrome, myocarditis/Takotsubo syndrome, acute mitral regurgitation, aortic dissection.
Laboratory analyses exposed elevated cardiac enzymes (hs-cTnI =244ng/L, TGO 69 U/l, CK MB 76 U/l), normal lipid and renal profile, mild normochromic normocytic anemia (Hg=11.8g/dl) but with normal iron levels. An echocardiogram was performed which revealed non dilated cardiac chambers: parasternal long axis view (PLAX): LV diastolic dimension = 45 mm, LV systolic dimension= 39mm; left atrium volume = 20ml (Simpson biplane method), parasternal short axis view (PSAX): RV diastolic dimension = 28mm, mild hypertrophy: PLAX: interventricular septum and posterior wall of 13 mm but with severely left ventricular systolic dysfunction (ejection fraction of 15% with Simpson biplane method), with akinetic basal walls and medium walls hypokinesia, moderate mitral regurgitation (PLAX: vena contracta = 5 mm) with no pericardial effusion or aortic dissection.
We admitted the patient in the Intensive Cardiac Care Unit and began to treat accordingly the cardiogenic shock with acute pulmonary edema. We started with a continuous intravenous inotropic dobutamine support in dose of 5 micrograms/ kg/min which was progressively increased to a dose of 20/micrograms/kg/min in 40 minutes in absence of not targeting a value of 65 mmHg for the mean arterial pressure (MAP). At that time, we considered it necessary to initiate norepinephrine as a vasopressor adjunct to inotropic therapy in a dose of 2 micrograms/minute and we reached a MAP of 70 mmHg with a dose of 5 micrograms/ minute (after 25 minutes). Nitroglycerine (5-15 micrograms/min) and furosemide (100 mg over 100 minutes) in continuous infusion protocol were also Figure  2 & 3) , and a left ventriculography (Figure 4 ) disclosed apical contractility but with mid-ventricular and basal akinesia, which raised suspicion of an inverted Takotsubo syndrome, although we did not have any information about a triggering stress event.
For the next 36 hours, the patient clinical status improved, with decreasing doses of dobutamine and norepinephrine until cessation.
Due to these findings, the diagnosis was unclear and we referred the patient for a cardiovascular magnetic resonance study to better characterize the myocardial tissue. CMR revealed myocardial edema in the mid-ventricular and basal walls (T2-weighted imaging), while T1-weighted late gadolinium enhancement images showed diffuse myocardial enhancement, consistent with a non-ischemic myocardial damage. Taking into consideration the myocardial edema, increased wall thickness with severe hypokinesia and diffuse enhancement, a diagnosis of acute myocarditis was firmly established. After 76 hours from admittance the patient was again in acute pulmonary edema but with very high blood pressure (250/130mmHg) which required i.v. nitroglycerin in high doses (50 micrograms/minute), furosemide (200mg over 100 minutes), morphine (single dose of 2 mg) and urapidil (intravenous bolus at a dose of 12.5 mg, followed by a continuous infusion at a rate of 10 mg/hr).
We performed a bedside abdominal ultrasound and noticed on the right adrenal gland topography a 50/34 mm tumor with cystic areas inside, highly suggestive of pheochromocytoma ( Figure 5 ). Confirmation of diagnosis came when we dosed urinary free catecholamines and fractionated metanephrines on the second episode of flash pulmonary edema. (Urinary -metanephrine 1498 μg/24 h (N <300); normetanephrine 9720 μg/ 24h (N <400); adrenaline 2 133 μg/24 h (N<18) ; noradrenaline 314 μg/24h (N<83); dopamine 922 μg/24 h h (N<460).
Taking into consideration all of the above, the positive diagnosis of adrenergic myocarditis due to catecholamine excess was made. A CT abdominal scan better identified the heterogeneous tumor and the patient was referred for a right laparoscopic adrenalectomy. (Figure 6 & 7) . At that moment, the medical treatment included: alfa blocker (doxazosin 1 mg o. 
Discussion
We report a case of acute myocarditis in a young female, c omplicated with cardiogenic shock and flash pulmonary edema, in the context of an undiagnosed pheochromocytoma. Our case report provides direct evidence supporting the pathogenic role of excess catecholamine secretion in the development of adrenergic myocarditis. Pheochromocytoma is a rare catecholamineproducing tumor, emerging from chromaffin cells of the adrenal medulla, with a vast majority of these tumors secreting both norepinephrine and epinephrine [2] . Palpitations, headaches and excessive sweating is the classic triad of this condition. Adrenergic myocarditis is a very rare presentation of pheochromocytoma and a particular cause of acute heart failure, with a pathophysiology which is not fully understood, although some autopsy studies revealed that myocardial inflammatory cell infiltrations and focal necrosis were found in 50% of patients who died from pheochromocytoma [3, 4] .
When facing a patient with cardiogenic shock of unknown origin, we must always take into consideration the presence of an underlying pheocromocytoma as a differential diagnosis, as well as other states of adrenergic hyperstimulation [5] . The reversibility of the myocardial affection in this phecromocytoma-associated myocardiopathy is common after the tumor resection [6] .
At this moment, there is no effective standardized therapy for acute myocarditis, besides the optimal care of heart failure and arrhythmias in accordance with evidence-based guidelines and specific etiology-driven therapy [7, 8] .
Conclusion
Adrenergic myocarditis, a rare pathological entity, represents a diagnostic and therapeutic challenge with important prognostic implications.
We believe that a multidisciplinary team (cardiologist, surgeon, radiologist, and anesthesiologist) is imperative in recognizing and managing these extremely difficult cases, while also discussing the therapeutic limitations induced by complications.
